Girls and women with ADHD; the impact of reproductive hormones across the lifespan

Add to favourites

Equal, evidence based, and timely interventions are at the core of sustainable and effective health care. However, girls and women with ADHD are an underserved group presenting with significant comorbidity, polypharmacy, and considerable health care utilisation. Predictable hormonal fluctuations across the female reproductive life are intimately associated with mental health outcomes. Gender bias and inadequate knowledge of biological sex differences create barriers which lead to long-term consequences for girls and women with ADHD.

Early detection, correct diagnosis and adequate treatment is crucial to prevent the wide range of adverse outcomes associated with ADHD. Hormonal fluctuations across the female reproductive life and menstrual cycle creates predictable phases of vulnerability for mental health.

This webinar will provide participants with an overview of research evidence, with the aim of supporting practitioners to bring this understanding into mental health and wellbeing formulation and treatment planning.

Webinar Recording

This webinar will provide participants with an overview of research evidence, with the aim of supporting practitioners to bring this understanding into mental health and wellbeing formulation and treatment planning.

Girls and women with ADHD; the impact of reproductive hormones across the lifespan

Here you are able to request access to view the recording of the Assessing ADHD in children and young people Webinar held on February 1st 2023, via MS Teams. 

To request access please complete this short form: https://forms.office.com/e/1p433Z43fs